OTHER 2015 WEBINARS!

Comments

Transcription

OTHER 2015 WEBINARS!
Liver Cancer Webinar Series: What You Need to Know
Presented by the Hepatitis B Foundation in collaboration with
Blue Faery: The Adrienne Wilson Liver Cancer Association
Did You Know?
Liver cancer is the 2nd leading cause of cancerrelated deaths and the 6th most common cancer
worldwide.
But if detected early, liver cancer can be treated or
cured with liver surgery or transplantation.
•
•
•
2015 WEBINARS
Presented for free by the
Hepatitis B Foundation
Clinical Trials in Liver Cancer
Expert Speakers:
Treatments for liver cancer are available.
New therapies are being studied in clinical
trials.
Support services can help families facing liver
cancer.
Learn More About Liver Cancer
Jill McNair
Director of Education, Outreach
and Community Support
The Center for Information &
Study on Clinical Research
Participation (CISCRP)
Join the Hepatitis B Foundation’s webinar series on
liver cancer to learn about treatment options,
clinical trials, and support services
Katelyn Levy, BS
Visit www.LiverCancerConnect.org
A patient-focused resource
with accurate information and
valuable support
Clinical Research Coordinator
Gastroenterology & Hepatology
Johns Hopkins Suburban
Hospital
Date: Wednesday, May 27
Time: 1:30 pm EDT; 10:30 am PDT
To register, click here
OTHER 2015 WEBINARS!
Support Services for Families Facing Liver Cancer
Expert Speakers: Karla Pillote, MSN, CANP, and Andrea Wilson, MPW
Date: Wednesday, June 3
Time: 1:30 pm EDT; 10:30 am PDT
To register, click here
Treatment Options for Liver Cancer
Expert Speaker: Robert G. Gish, MD
View webinar

Similar documents

Fatty Liver Disease Global Clinical Trials Review Industry Key Trends, Size, Growth, Shares and Forecast Research Report

Fatty Liver Disease Global Clinical Trials Review Industry Key Trends, Size, Growth, Shares and Forecast Research Report Non-alcoholic fatty liver disease (NAFLD) is a chronic liver disease that has been shown to progress to cirrhosis and hepatocellular carcinoma. This article reviews the prevalence of NAFLD and the factors associated this disorder, and with the more advanced stages of NAFLD.

More information

Non Alcoholic Fatty Liver Disease (NAFLD) Market Size, Share, Pipeline Review, H1 2016: Radiant Insights

Non Alcoholic Fatty Liver Disease (NAFLD) Market Size, Share, Pipeline Review, H1 2016: Radiant Insights Global Markets Direct's, 'Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline Review, H1 2016', provides an overview of the Non Alcoholic Fatty Liver Disease (NAFLD) pipeline landscape. Visit Us @ http://www.radiantinsights.com/research/non-alcoholic-fatty-liver-disease-nafld-pipeline-review-h1-2016

More information